TIM-3 therapy for Alzheimer’s is emerging as a groundbreaking approach that leverages the immune system to tackle one of the most challenging aspects of this neurodegenerative disease.Recent research demonstrates that inhibiting the TIM-3 checkpoint molecule can enable microglia to effectively clear amyloid plaques in the brain, thus potentially improving cognition in Alzheimer’s patients.